Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Advances in proteinuria-targeting therapy in IgAN
10
Mins
October 2024
Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…
Read more
12
Mins
30 Jun 2022
The Dual Role of Endothelin-1 and Angiotensin II in Disease Progression of Focal Segmental Glomerulosclerosis and IgA Nephropathy
This article details the diagnosis and treatment of IgA nephropathy and focal segmental glomerulosclerosis, as discussed in a symposium delivered as part of the European Renal Association (ERA) 59th Congress in Paris, 19th−22nd May 2022.
11
Mins
30 Jun 2022
Medium Cut-off Delivering Expanded Haemodialysis Therapy: Improving Clinical and Economic Outcomes in the Real World
In this symposium, the pathological background of the association between the uremic milieu and inflammation and pathways for poor outcomes in patients on haemodialysis (HD)
4
Mins
30 Jun 2022
Interview: John Sperati
Talking to John Sperati, Director of Nephrology Fellowship Training Program and Associate Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
4
Mins
30 Jun 2022
The Ground Is Full of Pitfalls: Association of Chronic Kidney Disease, Conflict Zones, and the Quality of Healthcare in Africa
Public health in sub-Saharan African countries is experiencing a double burden of diseases. Unfortunately, the health systems in sub-Saharan Africa are vulnerable, under-resourced, and unable to address these public health issues.
6
Mins
30 Jun 2022
Interview: Vivek Bhalla
The primary reason is that it’s the most impactful disease that affects nephrology. When I was in training, there was only one medicine…
5
Mins
30 Jun 2022
Focal Segmental Glomerulosclerosis: Histopathology Discussion
In focal segmental glomerulosclerosis (FSGS), some (not all) glomeruli are affected with sclerosis (focal), and each diseased glomerulus…
6
Mins
30 Jun 2022
Editor’s Pick: The Renal Effects of SGLT2 Inhibitors
Sodium–glucose co-transporters (SGLT) play an important role in glucose transport across epithelial cells. SGLT1….
6
Mins
30 Jun 2022
COVID-19-Associated Nephropathy: An Emerging Clinical Entity
In this article, the authors present the pathophysiology behind SARS-CoV-2-related kidney involvement and the development of COVID-19-associated nephropathy.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
19
Next »